Yesterday, the board of The Allstate Corp. ( ALL ) announced the sanction of a new share repurchase program worth $1.0 billion, commencing immediately. While the share buyback will be made
GlaxoSmithKline ( GSK ) recently announced that its inhalational anthrax candidate, raxibacumab, has received US Food and Drug Administration (FDA) approval. Raxibacumab was approved for